Skip to content
healthcare.dev

Betamethasone Sodium Phosphate and Betamethasone Acetate

NDC 76420-007, Betamethasone Sodium Phosphate and Betamethasone Acetate, injection, suspension, from Asclemed USA, Inc..

Product NDC
76420-007
Status
Listed
Labeler
Asclemed USA, Inc.
Dosage form
INJECTION, SUSPENSION
Route
INTRA-ARTICULAR, INTRALESIONAL, INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090747
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76420-007 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BETAMETHASONE ACETATE3 mg/mL
  • BETAMETHASONE SODIUM PHOSPHATE3 mg/mL

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Corticosteroid [EPC]

Package NDCNDC-11Package
76420-007-05764200007055 mL in 1 VIAL, MULTI-DOSE (76420-007-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c0a09d83-2405-450b-9f35-803d12823213

Use it

Look up 76420-007 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76420-007 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76420-007. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.